Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 is a potent cyclin-dependent kinase 9(CDK9) inhibitor that inhibits multiple myeloma tumors growth and induces apoptosis [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,230.00 | |
50 mg | 6-8 weeks | $ 1,610.00 | |
100 mg | 6-8 weeks | $ 2,450.00 |
Description | NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 is a potent cyclin-dependent kinase 9(CDK9) inhibitor that inhibits multiple myeloma tumors growth and induces apoptosis [1]. |
Molecular Weight | 324.29 |
Formula | C12H16N6O5 |
CAS No. | 22242-89-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NSC 107512 22242-89-3 inhibitor inhibit